ACHE and Alzheimer disease: Currently approved compounds for the treatment of mild to moderate AD stages—donepezil, rivastigmine, and galantamine provide symptomatic treatment by improving cholinergic neurotransmission via inhibition of acetylcholinesterase (AChE, E.C. 3.1.1.7).